Effectiveness and Safety of Large Gel Particle Hyaluronic Acid With Lidocaine for Correction of Midface Volume Deficit or Contour Deficiency
Authors:
- Amir MoradiAMAmir Moradi
- David BankDBDavid Bank
- Julius FewJFJulius Few
- John JosephJJJohn Joseph
- Jeffrey DoverJDJeffrey Dover
- Xiaoming LinXLXiaoming Lin
- Alessandra NogueiraANAlessandra Nogueira
- Jay MashburnJMJay Mashburn
- 1 June 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 42 (6) , 699-709
Abstract
Aging effects, such as facial flatness, increased tissue laxity, and soft tissue descent and deflation, contribute to midface deficiency. To evaluate whether large gel particle hyaluronic acid with lidocaine (LGP-HAL) is more effective in the treatment of midface deficiencies than no treatment. Subjects with mild to substantial loss of midface fullness were randomized 3:1 to LGP-HAL (Restylane Lyft; Galderma Laboratories, L.P., Fort Worth, TX) or no treatment. Treatment success was defined as at least 1-grade improvement in Medicis Midface Volume Scale (MMVS) on each side of the face at 8 weeks as assessed by a blinded evaluator. Secondary efficacy end points included MMVS score, global aesthetic improvement, and subject satisfaction. Significantly greater percent of subjects achieved treatment success in the LGP-HAL group compared to no treatment at all time points through Month 12 (p < .001). One year after initial treatment, 85% of subjects still had a global aesthetic improvement assessed by the treating investigator. Subject satisfaction demonstrated that LGP-HAL improved the aesthetic appearance of the midface. Most reported adverse events (80%) were mild in severity. The LGP-HAL treatment is well tolerated and provides significant improvement up to 12 months for the correction of midface deficiencies.Keywords
This publication has 13 references indexed in Scilit:
- Safety and Effectiveness of Large Gel Particle Hyaluronic Acid with Lidocaine for Correction of Midface Volume LossDermatologic Surgery, 2013
- Midface-Lifting: Evolution, Indications, and TechniqueFacial Plastic Surgery, 2013
- Validation of a Four-Point Photographic Scale for the Assessment of Midface Volume Loss and/or Contour DeficiencyPlastic and Reconstructive Surgery, 2012
- Comparison of the Rheological Properties of Viscosity and Elasticity in Two Categories of Soft Tissue Fillers: Calcium Hydroxylapatite and Hyaluronic AcidDermatologic Surgery, 2010
- Measuring Patient-Reported Outcomes in Facial Aesthetic Patients: Development of the FACE-QFacial Plastic Surgery, 2010
- Comparative Physical Properties of Hyaluronic Acid Dermal FillersDermatologic Surgery, 2009
- The Long-Term Efficacy and Safety of a Subcutaneously Injected Large-Particle Stabilized Hyaluronic Acid–Based Gel of NonAnimal Origin in Esthetic Facial ContouringDermatologic Surgery, 2009
- Hyaluronic acid gel fillers in the management of facial agingClinical Interventions in Aging, 2008
- Patient-Preferred Sites of Restylane Injection in Periocular and Facial Soft-Tissue AugmentationOphthalmic Plastic & Reconstructive Surgery, 2008
- Injectable hyaluronic acid for the correction of HIV‐associated facial lipoatrophyOtolaryngology–Head and Neck Surgery, 2007